Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

The list for the next round of medicines that ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

The drug was administered twice-daily using a nebuliser as a chronic maintenance therapy for people with COPD in the ENHANCE ... must surely now be on the hit-list of potential takeover targets.

Regeneron and Sanofi shares edged higher Friday after their drug to treat chronic obstructive pulmonary disease (COPD) received approval from the Food and Drug Administration (FDA). The drug ...

Patients with COPD often experience chronic cough, difficulty breathing, and reduced lung function. While the respiratory disease is not curable, it can be treated and managed with medications ...

and routinization of drug therapy are critical for optimal medication adherence in patients with COPD.

using National Drug Codes for anticholinergics, beta-agonists, and combination medications, and number of days covered by ≥1 COPD medication divided by total number of days. Variables were ...

An approval in COPD has been viewed by Wall Street analysts as a way to meet those lofty projections. But the drug’s success in the disease wasn’t a sure thing, as biologics have historically ...